Literature DB >> 27374487

Betulin attenuates atherosclerosis in apoE-/- mice by up-regulating ABCA1 and ABCG1.

Yu-Zhou Gui1,2, Hong Yan1,2, Fei Gao1,2, Cong Xi1,2, Hui-Hui Li1,2, Yi-Ping Wang1,2.   

Abstract

AIM: Betulin is a pentacyclic triterpenoid isolated from the bark of yellow and white birch trees with anti-cancer and anti-malaria activities. In this study we examined the effects of betulin on atherosclerosis in apoE-/- mice and the underlying mechanisms.
METHODS: Murine macrophage RAW264.7 cells and human monocyte-derived THP-1 cells were tested. Foam cell formation was detected with Oil Red O staining. Cholesterol efflux was assessed using [3H]-cholesterol efflux assay. The expression of ATP-binding cassette transporter A1 and G1 (ABCA1 and ABCG1) was examined using RT-PCR and Western-blotting. The ABCA1 promoter activity was evaluated using luciferase activity assay. Male apoE-/- mice fed on a high-fat-diet (HFD), and received betulin (20 and 40 mg·kg-1·d-1, ig) for 12 weeks. The macrophage content and ABCA1 expression in the aortic sinuses were evaluated with immunofluorescence staining. The hepatic, intestinal and fecal cholesterol were also analyzed in the mice.
RESULTS: In RAW264.7 cells, betulin (0.1-2.5 μg/mL) dose-dependently ameliorated oxLDL-induced cholesterol accumulation and enhanced cholesterol efflux. In both RAW264.7 and THP-1 cells, betulin increased the expression of ABCA1 and ABCG1 via suppressing the transcriptional repressors sterol-responsive element-binding proteins (SREBPs) that bound to E-box motifs in ABCA1 promoter, whereas E-box binding site mutation markedly attenuated betulin-induced ABCA1 promoter activity. In HFD-fed apoE-/- mice, betulin administration significantly reduced lesions in en face aortas and aortic sinuses. Furthermore, betulin administration significantly increased ABCA1 expression and suppressed macrophage positive areas in the aortic sinuses. Moreover, betulin administration improved plasma lipid profiles and enhanced fecal cholesterol excretion in the mice.
CONCLUSION: Betulin attenuates atherosclerosis in apoE-/- mice by promoting cholesterol efflux in macrophages.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27374487      PMCID: PMC5057233          DOI: 10.1038/aps.2016.46

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  45 in total

1.  Effect of JTT-705 on cholesteryl ester transfer protein and plasma lipid levels in normolipidemic animals.

Authors:  Hiroshi Okamoto; Yoko Iwamoto; Mimi Maki; Tomohiro Sotani; Fumihiko Yonemori; Korekiyo Wakitani
Journal:  Eur J Pharmacol       Date:  2003-04-11       Impact factor: 4.432

Review 2.  Protein sensors for membrane sterols.

Authors:  Joseph L Goldstein; Russell A DeBose-Boyd; Michael S Brown
Journal:  Cell       Date:  2006-01-13       Impact factor: 41.582

3.  The E-box motif in the proximal ABCA1 promoter mediates transcriptional repression of the ABCA1 gene.

Authors:  Xiao-Ping Yang; Lita A Freeman; Catherine L Knapper; Marcelo J A Amar; Alan Remaley; H Bryan Brewer; Silvia Santamarina-Fojo
Journal:  J Lipid Res       Date:  2002-02       Impact factor: 5.922

4.  Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.

Authors:  J J Repa; S D Turley; J A Lobaccaro; J Medina; L Li; K Lustig; B Shan; R A Heyman; J M Dietschy; D J Mangelsdorf
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

Review 5.  Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability.

Authors:  Dorien M Schrijvers; Guido R Y De Meyer; Arnold G Herman; Wim Martinet
Journal:  Cardiovasc Res       Date:  2006-09-16       Impact factor: 10.787

6.  Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice.

Authors:  Laurent Yvan-Charvet; Mollie Ranalletta; Nan Wang; Seongah Han; Naoki Terasaka; Rong Li; Carrie Welch; Alan R Tall
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  Inhibition of ABCA1 protein degradation promotes HDL cholesterol efflux capacity and RCT and reduces atherosclerosis in mice.

Authors:  LinZhang Huang; BaoYan Fan; Ang Ma; Philip W Shaul; HaiBo Zhu
Journal:  J Lipid Res       Date:  2015-03-11       Impact factor: 5.922

8.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

Authors:  A S Plump; J D Smith; T Hayek; K Aalto-Setälä; A Walsh; J G Verstuyft; E M Rubin; J L Breslow
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

9.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

Authors:  S H Zhang; R L Reddick; J A Piedrahita; N Maeda
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

10.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.

Authors: 
Journal:  J Am Coll Dent       Date:  2014
View more
  8 in total

1.  Clematichinenoside AR Alleviates Foam Cell Formation and the Inflammatory Response in Ox-LDL-Induced RAW264.7 Cells by Activating Autophagy.

Authors:  Yajing Diao
Journal:  Inflammation       Date:  2020-11-05       Impact factor: 4.092

2.  MicroRNA-124 inhibits macrophage cell apoptosis via targeting p38/MAPK signaling pathway in atherosclerosis development.

Authors:  Xue Liang; Lijun Wang; Manman Wang; Zhaohong Liu; Xing Liu; Baoshuai Zhang; Enzhao Liu; Guangping Li
Journal:  Aging (Albany NY)       Date:  2020-06-30       Impact factor: 5.682

Review 3.  Efficacy of Terpenoid in Attenuating Aortic Atherosclerosis in Apolipoprotein-E Deficient Mice: A Meta-Analysis of Animal Studies.

Authors:  Han Liu; Yang Zhang; Siqiao Sun; Shuai Wang
Journal:  Biomed Res Int       Date:  2019-07-17       Impact factor: 3.411

Review 4.  Analysis of Low Molecular Weight Substances and Related Processes Influencing Cellular Cholesterol Efflux.

Authors:  Dmitry Y Litvinov; Eugeny V Savushkin; Alexander D Dergunov
Journal:  Pharmaceut Med       Date:  2019-12

5.  Apolipoprotein E derived from CD11c+ cells ameliorates atherosclerosis.

Authors:  Manuela Sauter; Reinhard J Sauter; Henry Nording; Chaolan Lin; Marcus Olbrich; Stella Autenrieth; Christian Gleissner; Martin Thunemann; Nadia Otero; Esther Lutgens; Zouhair Aherrahrou; Dennis Wolf; Lars Zender; Sven Meuth; Robert Feil; Harald F Langer
Journal:  iScience       Date:  2021-12-25

6.  Exercise Ameliorates Atherosclerosis via Up-Regulating Serum β-Hydroxybutyrate Levels.

Authors:  Zhou Xu; Mingyue Zhang; Xinran Li; Yong Wang; Ronghui Du
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

7.  Baicalein inhibits macrophage lipid accumulation and inflammatory response by activating the PPARγ/LXRα pathway.

Authors:  Zi-Zhen Zhang; Xiao-Hua Yu; Wei-Hua Tan
Journal:  Clin Exp Immunol       Date:  2022-09-29       Impact factor: 5.732

8.  Knockdown of GAS5 Inhibits Atherosclerosis Progression via Reducing EZH2-Mediated ABCA1 Transcription in ApoE-/- Mice.

Authors:  Xiang-Dong Meng; Hua-Hong Yao; Li-Min Wang; Min Yu; Sheng Shi; Zhong-Xiang Yuan; Jian Liu
Journal:  Mol Ther Nucleic Acids       Date:  2019-11-12       Impact factor: 8.886

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.